Draft Genome Sequences of Two Multidrug-Resistant Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Strains Causing Bloodstream Infections

Genome Announcements
Eran CarassoShiri Navon-Venezia

Abstract

Multidrug-resistant (MDR) Klebsiella pneumoniae has become a major contributor to nosocomial bloodstream infections. Here, we report the draft genome sequences of two MDR extended-spectrum-β-lactamase-producing strains causing bloodstream infections. These sequenced genomes display a wide-spectrum virulence arsenal and will help us understand the genomic basis of K. pneumoniae virulence.

References

Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Mitchell J SchwaberYehuda Carmeli
Oct 12, 2005·Archives of Medical Research·Gonzalo M L Bearman, Richard P Wenzel
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Mitchell J SchwaberYehuda Carmeli
Feb 12, 2008·BMC Genomics·Ramy K AzizOlga Zagnitko
Oct 6, 2010·Current Opinion in Microbiology·Karen Bush
Oct 1, 2013·Expert Review of Anti-infective Therapy·Pierluigi VialeMario Tumbarello

❮ Previous
Next ❯

Datasets Mentioned

BETA
LJCD00000000

Software Mentioned

A5
miseq
Rapid Annotations using
Subsystems Technology ( RAST )
FastQC

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.